drugset / Trial / NCT02613013
Laser Peripheral Iridotomy Plus Laser Peripheral Iridoplasty for Primary Angle Closure
Unknown
240 enrolled
Sun Yat-sen University
Beijing Tongren Hospital · collabCentral South University · collabHe University · collabHebei Provincial Eye Hospital · collabHuazhong University of Science and Technology · collabThe Second Affiliated Hospital of Harbin Medical University · collabThe Third Hospital of HanDan · collabThird Affiliated Hospital of Third Military Medical University · collabWenzhou Medical University · collab
RandomizedParallel-groupOpen-labelTreatment
Summary
This is a 10-centre randomized controlled clinical trial to explore whether laser peripheral iridoplasty (LPIP) plus laser peripheral iridotomy (LPI) is more effective than single LPI to control the progression of primary angle closure with multi-mechanism based on the UBM classification.
Timeline
- Start
- 2015-10
- Primary completion
- 2020-03
- Completion
- 2022-04
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Background | Pilocarpine | Unknown | 2 % | Topical |
| Background | Proparacaine | Other / unclassified | — | Topical |